|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/7088 | |||
| A61K 39/00 | |||
| A61K 38/17 |
| (11) | Number of the document | 2566967 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11778233.4 |
| Date of filing the European patent application | 2011-05-04 | |
| (97) | Date of publication of the European application | 2013-03-13 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/035110 |
| Date | 2011-05-04 |
| (87) | Number | WO 2011/140173 |
| Date | 2011-11-10 |
| (30) | Number | Date | Country code |
| 331355 P | 2010-05-04 | US | |
| 331357 P | 2010-05-04 | US |
| (72) |
AGARWAL, Sandeep, K., US
SCHNEIDER, Daniel, J., US
BRENNER, Michael, B., US
|
| (73) |
The Brigham and Women`s Hospital, Inc.,
75 Francis Street, Boston, MA 02115,
US
Board of Regents, The University of Texas System, 201 West 7th Street, Austin, TX 78701, US |
| (54) | CADHERIN-11 ANTAGONIST FOR THE TREATMENT OF FIBROSIS |
| CADHERIN-11 ANTAGONIST FOR THE TREATMENT OF FIBROSIS |